Invention Grant
US08343958B2 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists
有权
3-氨基烷基-1,4-二氮杂环庚烷-2-酮黑皮质素-5-受体拮抗剂
- Patent Title: 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists
- Patent Title (中): 3-氨基烷基-1,4-二氮杂环庚烷-2-酮黑皮质素-5-受体拮抗剂
-
Application No.: US13154144Application Date: 2011-06-06
-
Publication No.: US08343958B2Publication Date: 2013-01-01
- Inventor: Mark Arnold Thomas Blaskovich , Peter Joseph Cassidy
- Applicant: Mark Arnold Thomas Blaskovich , Peter Joseph Cassidy
- Applicant Address: AU Milton Queensland
- Assignee: Mimetica Pty Ltd
- Current Assignee: Mimetica Pty Ltd
- Current Assignee Address: AU Milton Queensland
- Agency: Brinks Hofer Gilson & Lione
- Agent William R. Boudreaux
- Main IPC: C07D243/08
- IPC: C07D243/08 ; C07D401/04 ; A61K31/551
Abstract:
The present invention provides compounds of Formula (I) that are useful for modulating the biological activity of the melanocortin-5 receptor (MC5R). Compounds of this invention can be used to treat diseases and/or conditions in which downregulation of MC5R is beneficial. Such diseases and/or conditions include, but are not limited to, acne, seborrhea, seborrheic dermatitis, cancer, and inflammatory diseases.
Public/Granted literature
- US20110263572A1 3-AMINOALKYL-1,4-DIAZEPAN-2-ONE MELANOCORTIN-5-RECEPTOR ANTAGONISTS Public/Granted day:2011-10-27
Information query
